Japan, Sept. 30 -- IMMUNITYBIO INC has got intellectual property rights for 'MODIFIED NK-92 CELLS FOR TREATING CANCER.' Other related details are as follows:
Application Number: JP,2025-048124
Category (FI): A61K39/395@H,A61K40/15,C12N5/0783,C12N5/10,C07K14/55,A61K35/12,A61K35/17,C12N15/13,C07K14/705,C12N15/62@Z,C12N15/12,C07K19/00,A61P43/00,121,A61P35/02,A61P35/00,A61K40/31
Stage: Grant (IP right granted following substantive examination.)
Filing Date: March 24, 2025
Publication Date: June 12, 2025
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
